(2000). Acute effects of estradiol and progesterone on insulin, lipids and lipoproteins in postmenopausal women: a pilot study. Maturitas
(1985). Alaupovic P: Modulation of lipoprotein lipase activity by apolipoproteins.
(2002). Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian Indians.
(1995). Association between coronary heart disease and the apolipoprotein A-I/C-III/A-IV complex in a Japanese population. Hum Genet
(2010). Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese. Atherosclerosis
(2008). Associations of the apolipoprotein A-I gene polymorphism and serum lipid levels in the Guangxi Hei Yi Zhuang and Han populations.
(2005). atherosclerosis risk in communities study: Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study.
(1990). Baralle FE: Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia.
(2004). BR: Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study. Circulation
(1981). Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study.
(2010). Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men.
(1998). Ehnholm C: Haplotypes of the ApoA-I/C-III/A-IV gene cluster and familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol
(1991). EJ: Restriction fragment length polymorphisms of the apolipoprotein A-I, CIII, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease. Atherosclerosis
(2001). EM: An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science
(1993). GE: Genetic and environmental influences on serum lipid levels in twins.
(2004). gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia. Circ Res
(2003). GN: ApoA5 -1131T>C polymorphism is associated with triglyceride levels in Chinese men. Clin Genet
(1987). GS: Black-white differences in cholesterol levels of serum high-density lipoprotein subclasses among children: the Bogalusa Heart Study. Circulation
(2006). Helbecque N: Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men.
(2007). Hu FB: Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes. Atherosclerosis
(2005). Huang D: Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. Metabolism
(1984). Human apolipoprotein AI-CIII gene complex is located on chromosome 11. Arteriosclerosis
(2002). Humphries SE: Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet
(2005). Hutz MH: APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian children.
(2000). Interaction of alcohol and the G to A substitution at the promoter region of the apolipoprotein AI gene in determining plasma apolipoprotein AI levels in Yi and Han Chinese. Chin Med J (Engl)
(2011). Interactions of the apolipoprotein A5 gene polymorphisms and alcohol consumption on serum lipid levels. PLoS ONE
(1994). JC: Genetic analysis of a polymorphism in the human apolipoprotein A-I gene promoter: effect on plasma HDL-cholesterol levels.
(2006). JE: Consistent effects of genes involved in reverse cholesterol transport on plasma lipid and apolipoprotein levels in CARDIA participants. Arterioscler Thromb Vasc Biol
(2003). JP: Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids.
(1997). JQ: Association between genetic variations of apo AI-CIII-AIV cluster gene and hypertriglyceridemic subjects. Clin Chem
(1998). JQ: Linkage disequilibrium of the Apo AI-CIIIAIV gene cluster and their relationship to plasma triglyceride, apolipoprotein AI and CIII levels in Koreans. Mol Cells
(2004). JS: APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease. Atherosclerosis
(2008). JT: APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese. Clin Chim Acta
(2008). Kakkar VV: Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease. Lipids Health Dis
(2002). KL: Dietary and plasma lipid, lipoprotein, and apolipoprotein profiles among elderly Hispanics and non-Hispanics and their association with diabetes.
(2006). L: A genetic variant c.553G>T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population. Atherosclerosis
(2004). LA: Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol
(1999). Lack of association between genetic variations of apo A-I-C-III-A-IV gene cluster and myocardial infarction in a sample of European male: ECTIM study. Atherosclerosis
(1996). Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects.
(2007). Lehtimäki T: Apolipoprotein A-I/C-III/A-IV SstI and apolipoprotein B XbaI polymorphisms do not affect early functional and structural changes in atherosclerosis: the Cardiovascular Risk in Young Finns study. Circ J
(2005). Masmoudi AS: Association of SNP3 polymorphism in the apolipoprotein A-V gene with plasma triglyceride level in Tunisian type 2 diabetes. Lipids Health Dis
(2002). Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia. Clin Chem
(2001). Ordovas JM: Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis
(2003). Ordovas JM: The ApoA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore.
(1992). Pearson TA: Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease.
(2004). Pennacchio LA: Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11. Genomics
(2004). Pennacchio LA: Haplotypes in the APOA1-C3-A4-A5 gene cluster affect plasma lipids in both humans and baboons. Hum Mol Genet
(2006). Plasma triglyceride and HDL-cholesterol concentrations in Vietnamese girls are affected by lipoprotein lipase, but not apolipoprotein CIII polymorphism.
(1996). Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.
(1994). Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: the European Atherosclerosis research study. Genet Epidemiol
(1992). Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apoA IV concentrations. Hum Genet
(1989). RFLP studies in different ethnic groups. Atherosclerosis
RJ: The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. Clin Chem
(1993). Role of genetic variation at the apoAI-CIII-AIV gene cluster in determining plasma apoA-I levels in boys and girls. Genet Epidermiol
(1990). SE: G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med
(1992). SE: Interaction between a polymorphism of the apoA-I promoter region and smoking determines plasma levels of HDL and apoA-I. Arterioscler Thromb
(2006). Sing CF: Evidence for consistent intragenic and intergenic interactions between SNP effects in the APOA1/C3/A4/A5 gene cluster. Hum Hered
(2003). SW: A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet
(2002). The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese. Atherosclerosis
(2002). Tomura S: Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren. Hum Genet
(2001). Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet
(2009). Vrablik M: Impact of apolipoprotein A5 variants on statin treatment efficacy. Pharmacogenomics
(2004). Vráblík M: New variants in the apolipoprotein AV gene in individuals with extreme triglyceride levels. Physiol Res
(2010). Weixiong L: Apolipoprotein C-III gene polymorphism and several environmental factors with serum lipid levels in the Guangxi Hei Yi Zhuang and Han populations.
(2006). YS: Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis
(1997). YS: Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese. Hum Genet
(2008). YT: Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population. Clin Chim Acta
(2006). Zhenbiao N: Prevalence, awareness, treatment, control and risk factors of hypertension in the Guangxi Hei Yi Zhuang and Han populations. Hypertens Res